AU4669499A - New therapeutic use of pkb (proteine kinase b) enhancers - Google Patents

New therapeutic use of pkb (proteine kinase b) enhancers

Info

Publication number
AU4669499A
AU4669499A AU46694/99A AU4669499A AU4669499A AU 4669499 A AU4669499 A AU 4669499A AU 46694/99 A AU46694/99 A AU 46694/99A AU 4669499 A AU4669499 A AU 4669499A AU 4669499 A AU4669499 A AU 4669499A
Authority
AU
Australia
Prior art keywords
pkb
enhancers
therapeutic use
new therapeutic
proteine kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46694/99A
Inventor
Stephen James
Thomas Olin
Christina Reuterdahl
Harriet Ronnholm
Axel Stahlbom
Antek Wielburski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802023A external-priority patent/SE9802023D0/en
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of AU4669499A publication Critical patent/AU4669499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU46694/99A 1998-06-08 1999-06-08 New therapeutic use of pkb (proteine kinase b) enhancers Abandoned AU4669499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9802023A SE9802023D0 (en) 1998-06-08 1998-06-08 New therapeutic use
SE9802023 1998-06-08
US8970198P 1998-06-18 1998-06-18
US60089701 1998-06-18
PCT/SE1999/000989 WO1999064062A1 (en) 1998-06-08 1999-06-08 New therapeutic use of pkb (proteine kinase b) enhancers

Publications (1)

Publication Number Publication Date
AU4669499A true AU4669499A (en) 1999-12-30

Family

ID=26663323

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46694/99A Abandoned AU4669499A (en) 1998-06-08 1999-06-08 New therapeutic use of pkb (proteine kinase b) enhancers

Country Status (2)

Country Link
AU (1) AU4669499A (en)
WO (1) WO1999064062A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10225844A1 (en) * 2002-06-04 2003-12-18 Lang Florian sgk and nedd as diagnostic and therapeutic targets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241080A1 (en) * 1995-12-20 1997-06-26 Medical Research Council Control of protein synthesis, and screening method for agents
CA2294824A1 (en) * 1997-07-04 1999-01-14 Pharmacia & Upjohn Ab Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity
CA2304108A1 (en) * 1997-09-09 1999-03-18 The Regents Of The University Of California Inhibition of apoptotis using prosaposin receptor agonists

Also Published As

Publication number Publication date
WO1999064062A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU4308397A (en) Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
AU4429799A (en) Inhibitors of p38
AU1595197A (en) Novel pyrrolo{2,3-d}pyrimidines and their use as tyrosine kinase inhibitors
AU2002212226A1 (en) Use of indole derivatives for treating illnesses of the central nervous system
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU5835098A (en) Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
AU3891299A (en) Combination therapy for treatment of depression
AU3885900A (en) Inhibitors of the egf-receptor tyrosine kinase and their use
AU1676699A (en) Human signal transduction serine/threonine kinase
AU3094197A (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU2001238488A1 (en) Human kinases
AU2001277959A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU1189201A (en) Therapeutic compositions including protein kinase c inhibitors
AU2292301A (en) Human kinases
AU7687998A (en) Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
AU3082401A (en) Therapy of psoriasis
AU5340698A (en) Novel serine-threonine kinase gene
AU2002307996A1 (en) Mutants of desoxycytidine kinase having extended enzymatic activity
AU1522400A (en) Substituted pyrimidine compositions and methods of use
AU5446900A (en) Novel murine and human kinases
AU4669499A (en) New therapeutic use of pkb (proteine kinase b) enhancers
AU2001255573A1 (en) Human kinases
AU2003290966A1 (en) Modulation of nima-related kinase 6 expression
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase